Clinical Trials in Neurology provides a comprehensive overview of key concepts in patient-oriented investigation-both practical issues to consider and pitfalls to avoid. This wellwritten multidisciplinary text is unique in its focus on neurologic diseases and the specific challenges facing researchers in the field. The authors are international experts ranging from clinical neurologists and biostatisticians at academic medical centers and industry, to epidemiologists at the Food and Drug Administration.
The book is divided into 7 sections. Section 1, "The Role of Clinical Trials in Therapy Development," is an introduction to clinical neurology trials. A whole chapter devoted to the unique challenges in developing therapies for neurologic disorders addresses the paucity of biomarkers to assess the efficacy of experimental therapeutics, issues in testing devices and surgeries, and drug delivery to the central nervous system and measurement of central nervous system penetration.
Section 2, "Concepts in Biostatistics and Clinical Measurement," covers bias and random error, approaches to data analysis, and the selection of outcome measures. The outcomes chapter is particularly good at relating the key concepts to examples of neurologic diseases, and provides informative visuals about biomarkers and surrogate outcome measures.
Section 3 presents "Special Study Designs and Methods for Data Monitoring." The design chapters address selection and specific designs: futility (nonsuperiority), noninferiority, adap-tive, crossover, 2-period, and enrichment. Later chapters cover trial monitoring and post-marketing drug safety assessment. The material in this section tends to be rather dry. The adaptive design chapter and some of the others provide neurology-related examples that make the material more palatable. The section's tables and figures are also sparse. Those presented enhance the reader's ability to grasp the material, although some of the illustrations require concentrated review to understand.
Section 4 deals with "Ethical Issues" specific to the central nervous system, from the providing of informed consent by participants with cognitive impairment to sham surgical controls in Parkinson disease.
Section 5 covers "Regulatory Perspectives," including standards for neurologic drugs and premarket review of neurologic devices. One of strengths of the standards chapter is a discussion of pediatric regulatory acts by the US Food and Drug Administration, including the procedures needed to extend drug indications to children.
Section 6 gives hypothetical and real-life examples of "Clinical Trials in Common Neurological Disorders": Parkinson disease, Alzheimer disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, and insomnia. For each disorder, the authors discuss how trial design should address the biological basis of the disorder, goals of intervention, outcome measures, and available biomarkers. For example, the chapter on Alzheimer disease begins with a succinct summary of our current knowledge of the pathophysiology, followed by the goals of intervention, available treatments, and clinical trial measurement tools and biomarkers. The authors cite trials in which these measurement tools and biomarkers have been used. The chapter ends with safety issues and such implementation challenges as the participation of a study partner, the need to intervene early to impact disease trajectory, and recruit-ment of minorities, who are less likely to be diagnosed and treated early in their course. The authors comment in particular on the difficulty of convincing cognitively normal individuals to undergo lumbar punctures to learn whether they are at risk for Alzheimer disease.
Finally, Section 7 presents "Clinical Trial Planning and Implementation" from both academic and industry perspectives. The chapter on clinical trial planning features clear, informative tables and figures that guide the reader through important aspects of project management and budget planning. The section also covers reporting, monitoring, and fraud and abuse regulations governing research and development.
Major strengths of the text are the breadth of subject matter covered and the examples drawn from studies of many neurologic disorders. As the authors state in their Preface, however, the text should be regarded as only a starting point for learning about clinical trials and as a companion to formal coursework and practical experience. This is an important point, in that several chapters could have provided greater detail or more examples to illustrate their key concepts. In particular, including more illustrations would have enhanced the presentation of concepts and helped whet the reader's palate to learn more. One further limitation is that the emphasis on adult neurology allowed only a few examples of studies into pediatric neurologic conditions; however, the text is well referenced so that the reader can delve more deeply into areas of interest.
Overall, this text provides a valuable and informative overview and serves as an important reference for patient-oriented investigators in neurology.
